Parkinson disease
R Balestrino, AHV Schapira - European journal of neurology, 2020 - Wiley Online Library
Parkinson disease (PD) is the most common neurodegenerative movement disorder. In
Europe, prevalence and incidence rates for PD are estimated at approximately 108–257/100 …
Europe, prevalence and incidence rates for PD are estimated at approximately 108–257/100 …
Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
Polymorphism in the apolipoprotein E (APOE) gene is a major genetic risk determinant of
late-onset Alzheimer disease (AD), with the APOE* ε 4 allele conferring an increased risk …
late-onset Alzheimer disease (AD), with the APOE* ε 4 allele conferring an increased risk …
Lewy pathology in Parkinson's disease consists of crowded organelles and lipid membranes
Parkinson's disease, the most common age-related movement disorder, is a progressive
neurodegenerative disease with unclear etiology. Key neuropathological hallmarks are …
neurodegenerative disease with unclear etiology. Key neuropathological hallmarks are …
Genetics of Parkinson's disease: an introspection of its journey towards precision medicine
S Bandres-Ciga, M Diez-Fairen, JJ Kim… - Neurobiology of …, 2020 - Elsevier
ABSTRACT A substantial proportion of risk for Parkinson's disease (PD) is driven by
genetics. Progress in understanding the genetic basis of PD has been significant. So far …
genetics. Progress in understanding the genetic basis of PD has been significant. So far …
[HTML][HTML] Monogenic Parkinson's disease: genotype, phenotype, pathophysiology, and genetic testing
Genes | Free Full-Text | Monogenic Parkinson’s Disease: Genotype, Phenotype,
Pathophysiology, and Genetic Testing Next Article in Journal enChIP-Seq Analyzer: A …
Pathophysiology, and Genetic Testing Next Article in Journal enChIP-Seq Analyzer: A …
Parkinson's disease: proteinopathy or lipidopathy?
Lipids play a more significant role in Parkinson's disease and its related brain disorders than
is currently recognized, supporting a “lipid cascade”. The 14 kDa protein α-synuclein (αS) is …
is currently recognized, supporting a “lipid cascade”. The 14 kDa protein α-synuclein (αS) is …
The role of genetics in Parkinson's disease: a large cohort study in Chinese mainland population
Y Zhao, L Qin, H Pan, Z Liu, L Jiang, Y He, Q Zeng… - Brain, 2020 - academic.oup.com
This study aimed to determine the mutational spectrum of familial Parkinson's disease and
sporadic early-onset Parkinson's disease (sEOPD) in a mainland Chinese population and …
sporadic early-onset Parkinson's disease (sEOPD) in a mainland Chinese population and …
The genetic landscape of Parkinson's disease
A Lunati, S Lesage, A Brice - Revue neurologique, 2018 - Elsevier
The cause of Parkinson's disease (PD) remains unknown in most patients. Since 1997, with
the first genetic mutation known to cause PD described in SNCA gene, many other genes …
the first genetic mutation known to cause PD described in SNCA gene, many other genes …
Sex specific molecular networks and key drivers of Alzheimer's disease
Background Alzheimer's disease (AD) is a progressive and age-associated
neurodegenerative disorder that affects women disproportionally. However, the underlying …
neurodegenerative disorder that affects women disproportionally. However, the underlying …
Genetics of Parkinson's disease
Less than a quarter century after the discovery of SNCA as the first attributable gene in
Parkinson's disease (PD), our knowledge of the genetic architecture underlying this disease …
Parkinson's disease (PD), our knowledge of the genetic architecture underlying this disease …